ZKSCAN7P1

Across TCGA pan-cancer cohorts, ZKSCAN7P1 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated ZKSCAN7P1 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher ZKSCAN7P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ZKSCAN7P1 expression acts as an unfavorable survival marker.

SKCM, BLCA, and STAD are the cancer types where ZKSCAN7P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	II,III,IV	0.248	0.738	<.001	141	view →
BLCA	DFS	Tertile	III,IV	0.123	0.575	<.001	90	view →
STAD	OS	Tertile	All	0.485	0.690	.002	57	view →
LIHC	OS	Tertile	III,IV	0.059	0.738	<.001	45	view →
THCA	DFS	Tertile	All	0.526	0.947	<.001	36	view →
LUAD	OS	Tertile	III,IV	0.102	0.692	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

ZKSCAN7P1–SKCM (OS)

Open the SKCM breakdown →